주식/증권 📈 긍정적

Here's Why You Should Add NeuroPace Stock to Your Portfolio Now

Yahoo Finance 06/10/2026 02:38:00 PM 5회

요약

NPCE rides strong RNS adoption and AI tools nearing FDA review, with a mid-2026 IGE decision offering upside despite near-term losses.

원문 기사 보기

관련 뉴스

Is the stock market open on Friday, or will it close early for the Fourth of July?

Grindr shares jump 5% after Morgan Stanley upgrade to overweight

Haleon inks five-year partnership with Microsoft

Anthropic gets all-clear to let foreigners use latest model ahead of crucial IPO

뉴스 목록으로